Vienas receptes a\/s Grindeks veiksmei nav, ta\u010du t\u0101s pamat\u0101 60 gadu ilgaj\u0101 v\u0113stur\u0113 nemain\u012bgi ir biju\u0161i cilv\u0113ki un zin\u0101tne. Bez tiem neb\u016btu ne ori\u0123in\u0101lprodukta Mildron\u0101ts\u00ae<\/small>, ne ar\u012b citu produktu.<\/p>\n\n\n\n
\u2013 Uz\u0146\u0113muma pirms\u0101kumi mekl\u0113jami 1946. gad\u0101, kad nodibin\u0101ta vitam\u012bnu r\u016bpn\u012bca. 50. gadu otraj\u0101 pus\u0113 t\u0101 pievienota jaunizveidotajam PSR Latvijas Zin\u0101t\u0146u akad\u0113mijas (LZA) Organisk\u0101s sint\u0113zes instit\u016btam (OSI). Instit\u016bts kop\u0101 ar eksperiment\u0101lo r\u016bpn\u012bcu bija viens no vado\u0161ajiem centriem, kas Padomju Savien\u012bb\u0101 rad\u012bja jaunas z\u0101les, \u2014 vienubr\u012bd 80. gados katrs ceturtais PSRS re\u0123istr\u0113tais jaunais produkts bija rad\u012bts tie\u0161i \u0161eit. 1985. gad\u0101 eksperiment\u0101lajai r\u016bpn\u012bcai pievienoja otru LZA OSI ra\u017eotni. Tad ar\u012b par apvienot\u0101s r\u016bpn\u012bcas vad\u012bt\u0101ju k\u013c\u016bst Valdis J\u0101kobsons \u2014 tagad\u0113jais Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js. 90. gadu s\u0101kum\u0101 tiek nodibin\u0101ts Latvijas Valsts medic\u012bnisko prepar\u0101tu p\u0113tniec\u012bbas un ra\u017eo\u0161anas uz\u0146\u0113mums, ko nosauc \u2014 Grindeks. Nosaukuma pirm\u0101 da\u013ca \u2014 \u201cgrind\u201d \u2014 tapusi par godu Latvijas zin\u0101tniekam D\u0101vidam Hieron\u012bmam Grindelim. Otr\u0101 da\u013ca \u2014 \u201ceks\u201d \u2014 atspogu\u013co eksporta z\u012bm\u012bgo lomu uz\u0146\u0113muma izaugsm\u0113. Komp\u0101nija par savas izaugsmes atskaites punktu uzskata padomju laikos s\u0101kto eksportu uz Jap\u0101nu. Lai ar\u012b iek\u013c\u016b\u0161ana \u0161aj\u0101 tirg\u016b toreiz nebija viegla \u2014 tas bija t\u0101 v\u0113rts, atminas V. J\u0101kobsons. \u0160odien komp\u0101nija specializ\u0113jas sirds un asinsvadu, centr\u0101lo nervu sist\u0113mu ietekm\u0113jo\u0161u un pretv\u0113\u017ea medikamentu ra\u017eo\u0161an\u0101.<\/p>\n\n\n\n
Z\u0101les HIV terapijai p\u0113c 10 gadiem<\/strong><\/p>\n\n\n\n Padomju Savien\u012bbai sabr\u016bkot, vairs nebija neviena, kas rada un finans\u0113 jaunas z\u0101les. Bija j\u0101dom\u0101, ko dar\u012bt, \u2014 tad ar\u012b s\u0101kta gatavo z\u0101\u013cu ra\u017eo\u0161ana, lai ar\u012b no s\u0101kuma bija vien eksperiment\u0101l\u0101s iek\u0101rtas. \u201cKad daudzi izput\u0113ja, m\u0113s atrad\u0101m iesp\u0113ju, k\u0101 str\u0101d\u0101t t\u0101l\u0101k. Var\u0113ja jau visu no\u0113st, maks\u0101t lielas algas un nepamatoti tur\u0113t liekus cilv\u0113kus. M\u0113s taj\u0101 laik\u0101 atlaid\u0101m ap 250 cilv\u0113ku,\u201d Dienai st\u0101sta V. J\u0101kobsons. \u0160is solis bijis pareizs \u2014 ja visi \u0161ie cilv\u0113ki b\u016btu atst\u0101ti, vi\u0146i ar tik zem\u0101m alg\u0101m neko nedar\u012btu un r\u016bpn\u012bca izput\u0113tu. 90. gadu beig\u0101s \u2014 aptuveni vien\u0101 laik\u0101 ar uz\u0146\u0113muma privatiz\u0101ciju \u2014 Grindeks s\u0101ka ra\u017eot kop\u0101 ar OSI zin\u0101tniekiem rad\u012bto sirds un asinsvadu medikamentu Mildron\u0101ts<\/em>\u00ae<\/small>. S\u0101kums nebija viegls, ta\u010du \u0161odien \u0161is ir galvenais uz\u0146\u0113muma produkts, nodro\u0161inot ap 70% ie\u0146\u0113mumu. Tikai ar Mildron\u0101tu<\/em>\u00ae<\/small> gan nevarot dz\u012bvot, m\u016bsdien\u0101s svar\u012bgi rad\u012bt jaunus produktus. \u201cT\u0101 k\u0101 esam k\u013cuvu\u0161i tur\u012bg\u0101ki, varam at\u013cauties apm\u0113ram 10% komp\u0101nijas apgroz\u012bjuma ieguld\u012bt att\u012bst\u012bb\u0101 \u2014 tie ir 3\u20144 miljoni latu gad\u0101. Es nerun\u0101ju par iek\u0101rt\u0101m, bet par p\u0113tniec\u012bbas darbu,\u201d sac\u012bja V. J\u0101kobsons.<\/p>\n\n\n\n Nesen no Latvijas zin\u0101tniekiem nopirkts izgudrojums, kas k\u013cuvis par pamatu patenta pieteikumam ne tikai Latvij\u0101, bet ar\u012b \u0101rvalst\u012bs. Tagad tiek veikti kl\u012bniskie p\u0113t\u012bjumi, lai Mildron\u0101tu<\/em>\u00ae<\/small> kombin\u0101cij\u0101 ar citiem medikamentiem var\u0113tu izmantot HIV\/AIDS terapijai.<\/p>\n\n\n\n \u201cM\u0113s neesam pazi\u0146oju\u0161i, ka \u0101rst\u0113sim HIV un to ar\u012b nedar\u012bsim,\u201d strikti sac\u012bja Grindeks vad\u012bt\u0101js, skaidrojot: l\u012bdz\u012bgi k\u0101 onkolo\u0123isko slim\u012bbu \u0101rst\u0113\u0161an\u0101, ar\u012b HIV\/AIDS terapij\u0101 izmantotie medikamenti izraisa da\u017e\u0101das blakuspar\u0101d\u012bbas \u2014 t\u0101s m\u0113dz b\u016bt tik sp\u0113c\u012bgas, ka sirgsto\u0161s cilv\u0113ks to nesp\u0113j iztur\u0113t. Jaunais Grindeks medikaments HIV\/AIDS slimniekiem uzlabos dz\u012bves kvalit\u0101ti. Paies gan vismaz 10\u201412 gadi, l\u012bdz tas non\u0101ks tirg\u016b.<\/p>\n\n\n\n J\u0101kobsonu par premjeru? Grindeks pamatra\u017eo\u0161ana atrodas Latvij\u0101, ta\u010du komp\u0101nija str\u0101d\u0101 ar\u012b citviet. Ra\u017eotn\u0113m visp\u0101r ir j\u0101b\u016bt tuv\u0101k tirgum, ar\u012b \u2014 kur ir l\u0113t\u0101k. Latvij\u0101 jau vairs neesot tik l\u0113ti, jo pieaug darbasp\u0113ka izmaksas \u2014 lai ar\u012b t\u0101, uz\u0146\u0113muma eso\u0161aj\u0101 teritorij\u0101 ir iecer\u0113ta injekciju ra\u017eotnes b\u016bvniec\u012bba. Tuv\u0101ko tr\u012bs \u010detrus gadu laik\u0101 Grindeks <\/em>jaudu k\u0101pin\u0101\u0161anai pl\u0101nots ieguld\u012bt ap Ls 34 milj.<\/p>\n\n\n\n ***<\/p>\n\n\n\n Viedoklis<\/p>\n\n\n\n Pareiza strat\u0113\u0123ija<\/strong> Vienas receptes a\/s Grindeks veiksmei nav, ta\u010du t\u0101s pamat\u0101 60 gadu ilgaj\u0101 v\u0113stur\u0113 nemain\u012bgi ir biju\u0161i cilv\u0113ki un zin\u0101tne. Bez tiem neb\u016btu ne ori\u0123in\u0101lprodukta Mildron\u0101ts\u00ae,…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-259","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=259"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/259\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/strong>
Ja ir laba reput\u0101cija un kred\u012bta segums, naudu iek\u0101rt\u0101m var dab\u016bt, cik uziet. Probl\u0113mas ir ar izgl\u012btotu cilv\u0113ku tr\u016bkumu. Redzot \u201csaboj\u0101to\u201d Latvijas izgl\u012bt\u012bbas sist\u0113mu, Grindeks atbalsta m\u0101c\u012bbu iest\u0101des, savuk\u0101rt darbinieku motiv\u0113\u0161anai tiek maks\u0101ta konkur\u0113tsp\u0113j\u012bga alga. \u201cTo, ko \u0160lesers [Ain\u0101rs, LPP l\u012bderis] pirms v\u0113l\u0113\u0161an\u0101m sol\u012bja p\u0113c gadiem, tas mums ir jau \u0161odien \u2014 vid\u0113j\u0101 m\u0113ne\u0161alga ap 500 latiem. T\u0101 k\u0101 mani var celt par Ministru prezidentu jau \u0161odien, ja to vien uzskata par sasniegumu,\u201d ironiz\u0113ja V. J\u0101kobsons.<\/p>\n\n\n\n
Raina D\u016br\u0113ja, \u0136\u012bmijas un farm\u0101cijas ra\u017eot\u0101ju asoci\u0101cijas izpilddirektore<\/em>
\u2013 Viennoz\u012bm\u012bgi Grindeks ir vado\u0161ais un strauji augo\u0161ais farm\u0101cijas uz\u0146\u0113mums Baltij\u0101. Dom\u0101ju, ka Grindeks izaugsmes pamat\u0101 ir pareizi izv\u0113l\u0113ta strat\u0113\u0123ija produktu att\u012bst\u012bb\u0101. Visliel\u0101kos ie\u0146\u0113mumus komp\u0101nijai dod pa\u0161u izstr\u0101d\u0101tais produkts Mildron\u0101ts. Komp\u0101nija akt\u012bvi str\u0101d\u0101 pie \u0161\u012b produkta ilgtsp\u0113jas un ar\u012b pie citu, tai skait\u0101 ori\u0123in\u0101lproduktu, izstr\u0101des. Uz\u0146\u0113mumam ir \u013coti liela noz\u012bme nozares un Latvijas ekonomiskaj\u0101 att\u012bst\u012bb\u0101, \u0146emot v\u0113r\u0101 eksporta r\u0101d\u012bt\u0101jus un uz\u0146\u0113muma ieguld\u012bjumu izgl\u012bt\u012bbas un zin\u0101tnes veicin\u0101\u0161an\u0101.<\/p>\n","protected":false},"excerpt":{"rendered":"